These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 20005149)

  • 1. CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis.
    Zhang J; Patel L; Pienta KJ
    Cytokine Growth Factor Rev; 2010 Feb; 21(1):41-8. PubMed ID: 20005149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL2/CCR2 signaling in cancer pathogenesis.
    Hao Q; Vadgama JV; Wang P
    Cell Commun Signal; 2020 May; 18(1):82. PubMed ID: 32471499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL2 and CCR2 are Essential for the Formation of Osteoclasts and Foreign Body Giant Cells.
    Khan UA; Hashimi SM; Bakr MM; Forwood MR; Morrison NA
    J Cell Biochem; 2016 Feb; 117(2):382-9. PubMed ID: 26205994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment.
    Mizutani K; Sud S; McGregor NA; Martinovski G; Rice BT; Craig MJ; Varsos ZS; Roca H; Pienta KJ
    Neoplasia; 2009 Nov; 11(11):1235-42. PubMed ID: 19881959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells.
    Chang AL; Miska J; Wainwright DA; Dey M; Rivetta CV; Yu D; Kanojia D; Pituch KC; Qiao J; Pytel P; Han Y; Wu M; Zhang L; Horbinski CM; Ahmed AU; Lesniak MS
    Cancer Res; 2016 Oct; 76(19):5671-5682. PubMed ID: 27530322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
    Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
    Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective role of the inflammatory CCR2/CCL2 chemokine pathway through recruitment of type 1 cytotoxic γδ T lymphocytes to tumor beds.
    Lança T; Costa MF; Gonçalves-Sousa N; Rei M; Grosso AR; Penido C; Silva-Santos B
    J Immunol; 2013 Jun; 190(12):6673-80. PubMed ID: 23686489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth.
    Zhang J; Lu Y; Pienta KJ
    J Natl Cancer Inst; 2010 Apr; 102(8):522-8. PubMed ID: 20233997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response.
    Pahler JC; Tazzyman S; Erez N; Chen YY; Murdoch C; Nozawa H; Lewis CE; Hanahan D
    Neoplasia; 2008 Apr; 10(4):329-40. PubMed ID: 18392134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel recombinant fusion protein encoding a 20-amino acid residue of the third extracellular (E3) domain of CCR2 neutralizes the biological activity of CCL2.
    Izhak L; Wildbaum G; Zohar Y; Anunu R; Klapper L; Elkeles A; Seagal J; Yefenof E; Ayalon-Soffer M; Karin N
    J Immunol; 2009 Jul; 183(1):732-9. PubMed ID: 19535619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration.
    Loberg RD; Ying C; Craig M; Yan L; Snyder LA; Pienta KJ
    Neoplasia; 2007 Jul; 9(7):556-62. PubMed ID: 17710158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinoma.
    Wang Z; Xie H; Zhou L; Liu Z; Fu H; Zhu Y; Xu L; Xu J
    Oncotarget; 2016 Aug; 7(32):51525-51534. PubMed ID: 27409666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone.
    Lu Y; Chen Q; Corey E; Xie W; Fan J; Mizokami A; Zhang J
    Clin Exp Metastasis; 2009; 26(2):161-9. PubMed ID: 19002595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas.
    Flores-Toro JA; Luo D; Gopinath A; Sarkisian MR; Campbell JJ; Charo IF; Singh R; Schall TJ; Datta M; Jain RK; Mitchell DA; Harrison JK
    Proc Natl Acad Sci U S A; 2020 Jan; 117(2):1129-1138. PubMed ID: 31879345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL2/CCR2 Regulates the Tumor Microenvironment in HER-2/neu-Driven Mammary Carcinomas in Mice.
    Chen X; Wang Y; Nelson D; Tian S; Mulvey E; Patel B; Conti I; Jaen J; Rollins BJ
    PLoS One; 2016; 11(11):e0165595. PubMed ID: 27820834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recruitment of a myeloid cell subset (CD11b/Gr1 mid) via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis.
    Zhao L; Lim SY; Gordon-Weeks AN; Tapmeier TT; Im JH; Cao Y; Beech J; Allen D; Smart S; Muschel RJ
    Hepatology; 2013 Feb; 57(2):829-39. PubMed ID: 23081697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic.
    Zhang J; Patel L; Pienta KJ
    Prog Mol Biol Transl Sci; 2010; 95():31-53. PubMed ID: 21075328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers.
    Huang B; Lei Z; Zhao J; Gong W; Liu J; Chen Z; Liu Y; Li D; Yuan Y; Zhang GM; Feng ZH
    Cancer Lett; 2007 Jul; 252(1):86-92. PubMed ID: 17257744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indole-3-carbinol and 3',3'-diindolylmethane modulate androgen's effect on C-C chemokine ligand 2 and monocyte attraction to prostate cancer cells.
    Kim EK; Kim YS; Milner JA; Wang TT
    Cancer Prev Res (Phila); 2013 Jun; 6(6):519-29. PubMed ID: 23585426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL2 in the Tumor Microenvironment.
    O'Connor T; Heikenwalder M
    Adv Exp Med Biol; 2021; 1302():1-14. PubMed ID: 34286437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.